Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

HLA-DM Mediates Permissiveness of HLA-DPB1 T Cell Epitope Mismatches in Unrelated HCT

Maximilian Metzing, Pietro Crivello, Thuja Meurer, Michel G.D. Kester, ing., Dominik Megger, Weiqiang Chen, Peter Van Balen, MD, Marieke Griffioen, PhD, Peter A. Horn, Barbara Sitek, J.H.Frederik Falkenburg, MD PhD, Esteban Arrieta-Bolaños, Katharina Fleischhauer, MD

Blood (2019) 134 (Supplement_1): 3211.

https://doi.org/10.1182/blood-2019-129921

Published: 2019

Journal Articles

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2019) 134 (Supplement_1): 3281.

https://doi.org/10.1182/blood-2019-125369

Published: 2019

Journal Articles

Relative Contribution of Naïve and Memory T Cells to Alloreactivity in Hematopoietic Cell Transplantation

Esteban Arrieta-Bolaños, Maryam Mohamaddokht, Thuja Meurer, Pietro Crivello, Amin T. Turki, MD PhD, Peter A. Horn, Dietrich W. Beelen, J.H.Frederik Falkenburg, MD PhD, Katharina Fleischhauer, MD

Blood (2019) 134 (Supplement_1): 1923.

https://doi.org/10.1182/blood-2019-130273

Published: 2019

Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Blood (2017) 130 (Supplement 1): 848.

https://doi.org/10.1182/blood.V130.Suppl_1.848.848

Published: 2017

Journal Articles

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Shahinaz M. Gadalla, MD PhD MSC, Tao Wang, PhD, David Loftus, MD, Lyssa Friedman, RN, OCN, Casey Dagnall, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Ljubomir Buturovic, PhD, Marsha Blauwkamp, PhD, Jason Shelton, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Belynda Hicks, Kristine Jones, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 520.

https://doi.org/10.1182/blood.V128.22.520.520

Published: 2016

Journal Articles

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

Shahinaz M. Gadalla, MD PhD MSC, Bari J Ballew, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Belynda Hicks, Blanche P Alter, MD MPH, Bin Zhu, PhD, Weiyin Zhou, MS, Meredith Yeager, PhD, Tao Wang, PhD, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Neal Freedman, PhD MPH, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 68.

https://doi.org/10.1182/blood.V128.22.68.68

Published: 2016

Journal Articles

How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party

Raffaella Greco, MD, Fabio Ciceri, MD, Maddalena Noviello, PhD, Attilio Bondanza, MD PhD, Luca Vago, MD PhD, Giacomo Oliveira, PhD, Jacopo Peccatori, MD, Nicoletta Cieri, MD PhD, Annalisa Ruggeri, Ulrike Koehl, Katharina Fleischhauer, MD, Vanderson Rocha, MD PhD, Francesco Dazzi, PhD, Steffie Maria van der Werf, Sofie Rosanne Terwel, Antoine Toubert, Christian Chabannon, MD PhD, Chiara Bonini, MD

Blood (2016) 128 (22): 4581.

https://doi.org/10.1182/blood.V128.22.4581.4581

Published: 2016

Journal Articles

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Binod Dhakal, MD MS, Tao Wang, PhD, Michael D Haagenson, MS, Fenlu Zhu, PhD, Carolyn A. Keever-Taylor, PhD, Stephen R. Spellman, MBS, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Stephanie J. Lee, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 4678.

https://doi.org/10.1182/blood.V128.22.4678.4678

Published: 2016

Journal Articles

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

R. Coleman Lindsley, MD PhD, Wael Saber, MD MS, Brenton G. Mar, MD PhD, Robert A Redd, MS, Michael D Haagenson, MS, Peter V Grauman, BS, Stephen R. Spellman, MBS, Stephanie J. Lee, MD, Tao Wang, PhD, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Corey S. Cutler, MD MPH, Joseph H. Antin, MD, Donna S. Neuberg, ScD, Benjamin L. Ebert, MD PhD

Blood (2016) 128 (22): 69.

https://doi.org/10.1182/blood.V128.22.69.69

Published: 2016

Journal Articles

HLA Disparities Impact on Outcomes after Unmanipulated Haploidentical Hematopoietic Stem Cells Transplantation (HaploSCT) in Acute Leukemia: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Francesca Lorentino, MD, Fabio Ciceri, MD, Myriam Labopin, MD, Zafer Gülbas, MD, Yener Koc, MD, William Arcese, MD, Benedetto Bruno, MD PhD, Johanna Tischer, MD, Andrea Bacigalupo, MD, Didier Blaise, Giuseppe Messina, MD, Martin Bornhäuser, MD, Katharina Fleischhauer, MD, Dietrich W. Beelen, MD, Annalisa Ruggeri, MD PhD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2015) 126 (23): 399.

https://doi.org/10.1182/blood.V126.23.399.399

Published: 2015

Journal Articles

The Functional Distance Between Mismatched HLA-DPB1 Increases Risks of Relapse and Mortality after Unrelated Donor Hematopoietic Cell Transplantation for AML, ALL and MDS: A Refinement of the T Cell Epitope Group Algorithm for Permissive Mismatches

Dietrich W. Beelen, Prof. Dr. MD, Pietro Crivello, PhD, Andreas Heinold, Dr. sc. hum., Sabine Riebschläger, Falko M. Heinemann, Dr. rer. nat., Vera Rebmann, Priv.-Doz. Dr. rer. MDc., Monika Lindemann, Prof. Dr. MD, Hellmut Ottinger, Priv.-Doz. Dr. MD, Peter Horn, Prof. Dr. MD, Katharina Fleischhauer, MD

Blood (2015) 126 (23): 4288.

https://doi.org/10.1182/blood.V126.23.4288.4288

Published: 2015

Journal Articles

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

Abeer Madbouly, PhD, Tao Wang, PhD, Mark Albrecht, MSTAT, MBA, Vanja Paunic, PhD, Michael D Haagenson, MS, Cynthia Vierra-Green, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Navneet S. Majhail, MD MS, Stephanie J. Lee, MD MPH, Stephen R. Spellman, MBS, Martin Maiers, MS

Blood (2015) 126 (23): 3229.

https://doi.org/10.1182/blood.V126.23.3229.3229

Published: 2015

Journal Articles

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Valentina Gambacorta, MSc, Giacomo Oliveira, PhD, Laura Zito, MSc, Cristina Toffalori, PhD, Lara Crucitti, MD, Maddalena Noviello, PhD, Benedetta Mazzi, MSc, Raffaella Greco, MD, Maria Teresa Lupo Stanghellini, MD, Matteo G Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Katharina Fleischhauer, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2015) 126 (23): 743.

https://doi.org/10.1182/blood.V126.23.743.743

Published: 2015

Journal Articles

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Cristina Toffalori, PhD, Michela Riba, PhD, Laura Zito, BSc, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD PhD

Blood (2014) 124 (21): 427.

https://doi.org/10.1182/blood.V124.21.427.427

Published: 2014

Journal Articles

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 664.

https://doi.org/10.1182/blood.V124.21.664.664

Published: 2014

Journal Articles

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Brian Kornblit, MD PhD, Tao Wang, PhD, Stephanie J. Lee, MD MPH, Stephen R. Spellman, MBS, Xiaochun Zhu, MS, Katharina Fleischhauer, MD, Carlheinz Müller, MD PhD, Michael R. Verneris, MD, Julia S. Johansen, MD DMSci, Lars Vindelov, MD DMSci, Peter Garred, MD DMSci

Blood (2014) 124 (21): 1176.

https://doi.org/10.1182/blood.V124.21.1176.1176

Published: 2014

Journal Articles

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Blood (2014) 124 (21): 1185.

https://doi.org/10.1182/blood.V124.21.1185.1185

Published: 2014

Journal Articles

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Cristina Toffalori, PhD, Michela Riba, PhD, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, MD, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 3748.

https://doi.org/10.1182/blood.V122.21.3748.3748

Published: 2013

Journal Articles

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Luca Vago, MD, PhD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Cristina Toffalori, PhD, Giacomo Oliveira, MSc, Lorenza Chiesa, BSc, Benedetta Mazzi, BSc, Maurilio Ponzoni, MD, Matteo Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Elia Stupka, PhD

Blood (2013) 122 (21): 1369.

https://doi.org/10.1182/blood.V122.21.1369.1369

Published: 2013

Journal Articles

Modeling Antileukemic Adoptive Immunotherapy In Mouse-Humans Chimeras To Identify Novel Mechanisms Of Cancer Immunoediting

Giacomo Oliveira, MSc, Cristina Toffalori, PhD, Jose Manuel Garcia-Manteiga, PhD, Barbara Camisa, BSc, Lara Crucitti, MD, Dejan Lazarevic, MD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Claudio Bordignon, MD, Attilio Bondanza, MD, PhD, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Chiara Bonini, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 2017.

https://doi.org/10.1182/blood.V122.21.2017.2017

Published: 2013

NARROW

HLA-DM Mediates Permissiveness of HLA-DPB1 T Cell Epitope Mismatches in Unrelated HCT

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Relative Contribution of Naïve and Memory T Cells to Alloreactivity in Hematopoietic Cell Transplantation

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

HLA Disparities Impact on Outcomes after Unmanipulated Haploidentical Hematopoietic Stem Cells Transplantation (HaploSCT) in Acute Leukemia: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

The Functional Distance Between Mismatched HLA-DPB1 Increases Risks of Relapse and Mortality after Unrelated Donor Hematopoietic Cell Transplantation for AML, ALL and MDS: A Refinement of the T Cell Epitope Group Algorithm for Permissive Mismatches

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Modeling Antileukemic Adoptive Immunotherapy In Mouse-Humans Chimeras To Identify Novel Mechanisms Of Cancer Immunoediting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only